Cargando…

The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model

AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Emamipour, Sajad, Pagano, Eva, Di Cuonzo, Daniela, Konings, Stefan R. A., van der Heijden, Amber A., Elders, Petra, Beulens, Joline W. J., Leal, Jose, Feenstra, Talitha L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156453/
https://www.ncbi.nlm.nih.gov/pubmed/35445871
http://dx.doi.org/10.1007/s00592-022-01891-2
_version_ 1784718454956228608
author Emamipour, Sajad
Pagano, Eva
Di Cuonzo, Daniela
Konings, Stefan R. A.
van der Heijden, Amber A.
Elders, Petra
Beulens, Joline W. J.
Leal, Jose
Feenstra, Talitha L.
author_facet Emamipour, Sajad
Pagano, Eva
Di Cuonzo, Daniela
Konings, Stefan R. A.
van der Heijden, Amber A.
Elders, Petra
Beulens, Joline W. J.
Leal, Jose
Feenstra, Talitha L.
author_sort Emamipour, Sajad
collection PubMed
description AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability of a model developed from one setting to another. We evaluate the transferability of the MICADO model, developed for the Dutch 2007 setting, in two different settings using a range of adjustment steps. MICADO predicts micro- and macrovascular events at the population level. METHODS: MICADO simulation results were compared to observed events in an Italian 2000–2015 cohort (Casale Monferrato Survey [CMS]) and in a Dutch 2008–2019 (Hoorn Diabetes Care Center [DCS]) cohort after adjusting the demographic characteristics. Additional adjustments were performed to: (1) risk factors prevalence at baseline, (2) prevalence of complications, and (3) all-cause mortality risks by age and sex. Model validity was assessed by mean average percentage error (MAPE) of cumulative incidences over 10 years of follow-up, where lower values mean better accuracy. RESULTS: For mortality, MAPE was lower for CMS compared to DCS (0.38 vs. 0.70 following demographic adjustment) and adjustment step 3 improved it to 0.20 in CMS, whereas step 2 showed best results in DCS (0.65). MAPE for heart failure and stroke in DCS were 0.11 and 0.22, respectively, while for CMS was 0.42 and 0.41. CONCLUSIONS: The transferability of the MICADO model varied by event and per cohort. Additional adjustments improved prediction of events for MICADO. To ensure a valid model in a new setting it is imperative to assess the impact of adjustments in terms of model accuracy, even when this involves the same country, but a new time period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01891-2.
format Online
Article
Text
id pubmed-9156453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-91564532022-06-02 The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model Emamipour, Sajad Pagano, Eva Di Cuonzo, Daniela Konings, Stefan R. A. van der Heijden, Amber A. Elders, Petra Beulens, Joline W. J. Leal, Jose Feenstra, Talitha L. Acta Diabetol Original Article AIMS: Valid health economic models are essential to inform the adoption and reimbursement of therapies for diabetes mellitus. Often existing health economic models are applied in other countries and settings than those where they were developed. This practice requires assessing the transferability of a model developed from one setting to another. We evaluate the transferability of the MICADO model, developed for the Dutch 2007 setting, in two different settings using a range of adjustment steps. MICADO predicts micro- and macrovascular events at the population level. METHODS: MICADO simulation results were compared to observed events in an Italian 2000–2015 cohort (Casale Monferrato Survey [CMS]) and in a Dutch 2008–2019 (Hoorn Diabetes Care Center [DCS]) cohort after adjusting the demographic characteristics. Additional adjustments were performed to: (1) risk factors prevalence at baseline, (2) prevalence of complications, and (3) all-cause mortality risks by age and sex. Model validity was assessed by mean average percentage error (MAPE) of cumulative incidences over 10 years of follow-up, where lower values mean better accuracy. RESULTS: For mortality, MAPE was lower for CMS compared to DCS (0.38 vs. 0.70 following demographic adjustment) and adjustment step 3 improved it to 0.20 in CMS, whereas step 2 showed best results in DCS (0.65). MAPE for heart failure and stroke in DCS were 0.11 and 0.22, respectively, while for CMS was 0.42 and 0.41. CONCLUSIONS: The transferability of the MICADO model varied by event and per cohort. Additional adjustments improved prediction of events for MICADO. To ensure a valid model in a new setting it is imperative to assess the impact of adjustments in terms of model accuracy, even when this involves the same country, but a new time period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01891-2. Springer Milan 2022-04-21 2022 /pmc/articles/PMC9156453/ /pubmed/35445871 http://dx.doi.org/10.1007/s00592-022-01891-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Emamipour, Sajad
Pagano, Eva
Di Cuonzo, Daniela
Konings, Stefan R. A.
van der Heijden, Amber A.
Elders, Petra
Beulens, Joline W. J.
Leal, Jose
Feenstra, Talitha L.
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title_full The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title_fullStr The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title_full_unstemmed The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title_short The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
title_sort transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the micado model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156453/
https://www.ncbi.nlm.nih.gov/pubmed/35445871
http://dx.doi.org/10.1007/s00592-022-01891-2
work_keys_str_mv AT emamipoursajad thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT paganoeva thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT dicuonzodaniela thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT koningsstefanra thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT vanderheijdenambera thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT elderspetra thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT beulensjolinewj thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT lealjose thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT feenstratalithal thetransferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT emamipoursajad transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT paganoeva transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT dicuonzodaniela transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT koningsstefanra transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT vanderheijdenambera transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT elderspetra transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT beulensjolinewj transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT lealjose transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel
AT feenstratalithal transferabilityandvalidityofapopulationlevelsimulationmodelfortheeconomicevaluationofinterventionsindiabetesthemicadomodel